Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada · Delayed Price · Currency is CAD 0.1150
+0.0050 (4.55%)
Oct 31, 2025, 1:13 PM EDT
Pharmala Biotech Holdings Company Description
Pharmala Biotech Holdings Inc., doing business as PharmAla, a biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.
It offers its MDMA drug active pharmaceutical ingredients under the LaNeo brand. The company is headquartered in Vancouver, Canada.
Pharmala Biotech Holdings Inc.
| Country | Canada |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Nicholas Kadysh |
Contact Details
Address: 1055 West Georgia Street Vancouver, British Columbia V6E 4N7 Canada | |
| Website | pharmala.ca |
Stock Details
| Ticker Symbol | MDMA |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | September - August |
| Reporting Currency | CAD |
| ISIN Number | CA71719L1067 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Nicholas Kadysh | Director, President and Chief Executive Officer |
| Harpreet Kaur | Vice President of Research |
| William Avery C.A., CPA | Chief Financial Officer |
| Dr. Farnoud Kazemzadeh | Chief Operating Officer |
| Ali Taghva | Chief Commercial Officer |